UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...
The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...
The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising ...
Merus (MRUS) announced that the FDA has granted Breakthrough Therapy designation to petosemtamab in combination with pembrolizumab for the ...
NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the ...
Irish Independent on MSN3h
Ask the doctor: I have a strange growth on my eyelid – should I be concerned?Question: I recently noticed a strange growth on my bottom eyelid. It isn’t coming out of a hair follicle, and it isn’t a ...
Israel-based clinical-stage company Purple Biotech today announced it is advancing into a Phase II study with NT219 in ...
Shares of Merus N.V. (NASDAQ: MRUS) are trading higher Tuesday after the company announced that the U.S. Food and Drug ...
After Teddi Mellencamp underwent emergency brain surgery for her tumors, the Real Housewives of Beverly Hills star’s sister Justice Mellencamp shared an update on her recovery.
NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and neck cancer drugs pembrolizumab (Keytruda) or cetuximab ...
Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback